Glaukos (GKOS) Capital Expenditures (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -66.60% |
| Dec 31, 2025 | 200.00% |
| Sep 30, 2025 | -173.61% |
| Jun 30, 2025 | 3,108.17% |
| Mar 31, 2025 | -71.03% |
| Dec 31, 2024 | 19.52% |
| Sep 30, 2024 | -32.53% |
| Jun 30, 2024 | 122.00% |
| Mar 31, 2024 | 151.82% |
| Dec 31, 2023 | 80.28% |
| Sep 30, 2023 | -264.29% |
| Jun 30, 2023 | -16.53% |
| Mar 31, 2023 | 137.86% |
| Dec 31, 2022 | -402.15% |
| Sep 30, 2022 | -35.76% |
| Jun 30, 2022 | 42.35% |
| Mar 31, 2022 | -85.50% |
| Dec 31, 2021 | 273.17% |
| Sep 30, 2021 | -206.50% |
| Jun 30, 2021 | 541.74% |
| Mar 31, 2021 | 79.39% |
| Dec 31, 2020 | 67.45% |
| Sep 30, 2020 | -53.03% |
| Jun 30, 2020 | 248.72% |
| Mar 31, 2020 | -34.51% |
| Dec 31, 2019 | 18.57% |
| Sep 30, 2019 | -46.21% |
| Jun 30, 2019 | 187.56% |
| Mar 31, 2019 | -91.41% |
| Dec 31, 2018 | 942.92% |
| Sep 30, 2018 | -4.34% |
| Jun 30, 2018 | -39.00% |
| Mar 31, 2018 | -32.94% |
| Dec 31, 2017 | -22.00% |
| Sep 30, 2017 | 81.69% |
| Jun 30, 2017 | 72.50% |
| Mar 31, 2017 | -62.78% |
| Dec 31, 2016 | -32.32% |
| Sep 30, 2016 | 258.31% |
| Jun 30, 2016 | 123.34% |
| Mar 31, 2016 | 0.53% |
| Dec 31, 2015 | 104.92% |
| Dec 31, 2014 | 8.58% |